1 New randomized, controlled
trials have become available on oral P2Y(12) inhibitors in ac
2 Similarly, fewer clinical
trials have been completed in PDAC (n = 608) compared with br
3 As of now, several clinical
trials have been conducted to assess the benefits of TRT-base
4 To address this, several treatment de-escalation
trials have been conducted, but only a few of these have prov
5 Numerous clinical
trials have been launched to identify effective treatments fo
6 Two blinded randomized controlled
trials have been published, one with level I evidence (Yale-B
7 gnant adults, few published data from randomised controlled
trials have compared the safety and efficacy of any integrase
8 Mendelian randomization studies and randomized
trials have conclusively demonstrated that lower low-density
9 Clinical
trials have demonstrated health status benefit of transcathet
10 Randomized clinical
trials have demonstrated that catheter ablation for atrial fi
11 Well-conducted
trials have demonstrated that long-term opioid agonist therap
12 s haematopoietic stem cell transplantation, and prospective
trials have demonstrated the potency of immunotherapeutic app
13 Numerous randomized clinical
trials have demonstrated the superiority of thin-strut biodeg
14 Meta-analyses of these
trials have established the safety of statins with regard to
15 More recent clinical
trials have focused on conditions mediated by LLPCs and have
16 Some
trials have found that patients from the United States derive
17 Community randomised
trials have had mixed success in implementing combination pre
18 get specific immune pathways, and findings from prospective
trials have indicated that less-restrictive, empiric, elimina
19 Nonetheless, data from clinical
trials have led to the approval of the XPO1 inhibitor selinex
20 peutic options for metastatic UM are limited, with clinical
trials having little impact.
21 ate latent HIV in preclinical animal models and in clinical
trials have measured HIV induction in the peripheral blood wi
22 ship of heart failure (HF) guideline citations and clinical
trials have not been examined.
23 iologic plausibility and causality as randomized controlled
trials have not been performed.
24 Multiple small
trials have proposed that the administration of glucocorticoi
25 d therapy for hypertension, and randomized, sham-controlled
trials have provided proof-of-principle data for its blood pr
26 Moreover, almost all
trials have quantified treatment effects by using the hazard
27 Phase III adjuvant
trials have reported significant benefits in both relapse-fre
28 Earlier
trials have revealed mixed outcomes and early outcomes from a
29 Two large clinical
trials have shown a reduced rate of breast cancer development
30 Previous randomised
trials have shown an overwhelming benefit of mechanical throm
31 are adjuvant therapy, although data from several randomized
trials have shown improved outcomes with neoadjuvant treatmen
32 Although clinical
trials have shown improvements in motor function in infants a
33 s with scalability and interdonor variability, and clinical
trials have shown inconsistent outcomes(3,4).
34 Outcome data from procalcitonin-guided therapy
trials have shown similar mortality, but the essential questi
35 Randomized
trials have shown that initiating breast cancer screening bet
36 n or other indications for anticoagulation, recent clinical
trials have shown the benefit of double therapy with full-dos
37 targets within the immune pathogenic process, and the four
trials have similarities and differences that mean they might
38 Results from more recent
trials have stimulated a renewed interest in hypofractionatio
39 However, no
trials have studied whether or when women can safely stop scr
40 in preclinical models of neonatal brain injury, and phase 2
trials have suggested possible efficacy; however, the benefit
41 lerated fibrosis progression, yet few randomized controlled
trials have tested clinic-based alcohol interventions.
42 Though several hundred clinical
trials have tested immune-based approaches in childhood cance
43 Four randomised controlled
trials have tested the efficacy of three new therapies (eculi
44 North American HF
trials had the highest likelihood of having a woman as first
45 ues: (1) how to effectively and efficiently determine which
trials have the best chance of benefiting current and future
46 gs that have already advanced through human clinical safety
trials have the potential to be approved more quickly than de
47 Early clinical
trials have thus far focused on safety and target engagement
48 These
trials have used the noninferiority trial approach.
49 Findings from randomized controlled
trials have yielded conflicting results on the association be
50 Although some clinical
trials have yielded promising results, others have shown no c